Skip to main content

Advertisement

SpringerLink
Log in

Prevention of invasive fungal infections in lung transplant patients

  • Published:
Current Fungal Infection Reports Aims and scope Submit manuscript

Abstract

Lung transplantation is associated with a relatively high incidence of invasive fungal infections that directly affect the morbidity and mortality associated with the procedure. In addition, these infections may have immunologic consequences that play a role in the evolution of lung injury syndromes and result in earlier loss of graft than otherwise would be expected to occur. This article is an overview of the epidemiology and prophylaxis of invasive fungal infections following lung transplantation.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References and Recommended Reading

  1. Grossi P, Farina C, Fiocchi R, Dalla Gasperina D: Prevalence and outcome of invasive fungal infections in 1963 thoracic organ transplant recipients: a multicenter retrospective study. Italian Study Group of Fungal Infections in Thoracic Organ Transplant Recipients. Transplantation 2000, 70:112–116.

    PubMed  CAS  Google Scholar 

  2. Singh N: Antifungal prophylaxis for solid organ transplant recipients: seeking clarity amidst controversy. Clin Infect Dis 2000, 31:545–553.

    Article  PubMed  CAS  Google Scholar 

  3. Kramer MR, Stoehr C, Lewiston NJ, et al.: Trimethoprimsulfamethoxazole prophylaxis for Pneumocystis carinii infections in heart-lung and lung transplantation—how effective and for how long? Transplantation 1992, 53:586–589.

    Article  PubMed  CAS  Google Scholar 

  4. Paradis IL, Williams P: Infection after lung transplantation. Semin Respir Infect 1993, 8:207–215.

    PubMed  CAS  Google Scholar 

  5. Bodey G, Bueltmann B, Duguid W, et al.: Fungal infections in cancer patients: an international autopsy survey. Eur J Clin Microbiol Infect Dis 1992, 11:99–109.

    Article  PubMed  CAS  Google Scholar 

  6. Frost AE: Role of infections, pathogenesis, and management in lung transplantation. Transplant Proc 1999, 31:175–177.

    Article  PubMed  CAS  Google Scholar 

  7. Fishman JA: Infection in solid-organ transplant recipients. N Engl J Med 2007, 357:2601–2614.

    Article  PubMed  CAS  Google Scholar 

  8. Palmer SM, Perfect JR, Howell DN, et al.: Candidal anastomotic infection in lung transplant recipients: successful treatment with a combination of systemic and inhaled antifungal agents. J Heart Lung Transplant 1998, 17:1029–1033.

    PubMed  CAS  Google Scholar 

  9. Singh N, Husain S: Aspergillus infections after lung transplantation: clinical differences in type of transplant and implications for management. J Heart Lung Transplant 2003, 22:258–266.

    Article  PubMed  Google Scholar 

  10. Palmer SM, Alexander BD, Sanders LL, et al.: Significance of blood stream infection after lung transplantation: analysis in 176 consecutive patients. Transplantation 2000, 69:2360–2366.

    Article  PubMed  CAS  Google Scholar 

  11. Iversen M, Burton CM, Vand S, et al.: Aspergillus infection in lung transplant patients: incidence and prognosis. Eur J Clin Microbiol Infect Dis 2007, 26:879–886.

    Article  PubMed  CAS  Google Scholar 

  12. Pappas PG, Kauffman C, Alexander B, et al.: Prospective surveillance of invasive fungal infections (IFIs) among organ transplant recipients (OTRs) in the US, 2001–2006: review of TRANSNET (M-1195). Presented at the 47th Interscience Conference on Antimicrobial Agents and Chemotherapy. Chicago, IL; September 17–20, 2007.

  13. Morgan J, Wannemuehler KA, Marr KA, et al.: Incidence of invasive aspergillosis following hematopoietic stem cell and solid organ transplantation: interim results of a prospective multicenter surveillance program. Med Mycol 2005, 43(Suppl 1):S49–S58.

    Article  PubMed  Google Scholar 

  14. Silveira FP, Husain S: Fungal infections in solid organ transplantation. Med Mycol 2007, 45:305–320.

    Article  PubMed  Google Scholar 

  15. Kramer MR, Marshall SE, Starnes VA, et al.: Infectious complications in heart-lung transplantation. Analysis of 200 episodes. Arch Intern Med 1993, 153:2010–2016.

    Article  PubMed  CAS  Google Scholar 

  16. Sole A, Morant P, Salavert M, et al.: Aspergillus infections in lung transplant recipients: risk factors and outcome. Clin Microbiol Infect 2005, 11:359–365.

    Article  PubMed  CAS  Google Scholar 

  17. Cahill BC, Hibbs JR, Savik K, et al.: Aspergillus airway colonization and invasive disease after lung transplantation. Chest 1997, 112:1160–1164.

    Article  PubMed  CAS  Google Scholar 

  18. Yeldandi V, Laghi F, McCabe MA, et al.: Aspergillus and lung transplantation. J Heart Lung Transplant 1995, 14:883–890.

    PubMed  CAS  Google Scholar 

  19. Westney GE, Kesten S, De Hoyos A, et al.: Aspergillus infection in single and double lung transplant recipients. Transplantation 1996, 61:915–919.

    Article  PubMed  CAS  Google Scholar 

  20. Alexander BD, Tapson VF: Infectious complications of lung transplantation. Transpl Infect Dis 2001, 3:128–137.

    Article  PubMed  CAS  Google Scholar 

  21. Nunley DR, Ohori P, Grgurich WF, et al.: Pulmonary aspergillosis in cystic fibrosis lung transplant recipients. Chest 1998, 114:1321–1329.

    Article  PubMed  CAS  Google Scholar 

  22. Alexander BD, Schell W: Hyalohyphomycosis. In Atlas of Fungal Infections. Edited by Kauffman C and Mandell GL. Philadelphia: Current Medicine Group; 2006.

    Google Scholar 

  23. Husain S, Wagener MM, Singh N: Cryptococcus neoformans infection in organ transplant recipients: variables influencing clinical characteristics and outcome. Emerg Infect Dis 2001, 7:375–381.

    Article  PubMed  CAS  Google Scholar 

  24. Vilchez R, Shapiro R, McCurry K, et al.: Longitudinal study of cryptococcosis in adult solid-organ transplant recipients. Transpl Int 2003, 16:336–340.

    Article  PubMed  Google Scholar 

  25. Singh N, Alexander BD, Lortholary O, et al.: Pulmonary cryptococcosis in solid organ transplant recipients: clinical relevance of serum cryptococcal antigen. Clin Infect Dis 2008, 46:e12–e18.

    Article  PubMed  Google Scholar 

  26. Freifeld A, Kauffman C, Pappas PG, et al.: Endemic fungal infections (EFIs) among solid organ transplant recipients (SOTRs). Presented at the 43rd Annual Meeting of Infectious Disease Society of America. San Francisco, CA; October 6–9, 2005.

  27. Freifeld AG, Iwen PC, Lesiak BL, et al.: Histoplasmosis in solid organ transplant recipients at a large Midwestern university transplant center. Transpl Infect Dis 2005, 7:109–115.

    Article  PubMed  CAS  Google Scholar 

  28. Limaye AP, Connolly PA, Sagar M, et al.: Transmission of Histoplasma capsulatum by organ transplantation. N Engl J Med 2000, 343:1163–1166.

    Article  PubMed  CAS  Google Scholar 

  29. Vail GM, Young RS, Wheat LJ, et al.: Incidence of histoplasmosis following allogeneic bone marrow transplant or solid organ transplant in a hyperendemic area. Transpl Infect Dis 2002, 4:148–151.

    Article  PubMed  CAS  Google Scholar 

  30. Blair JE, Logan JL: Coccidioidomycosis in solid organ transplantation. Clin Infect Dis 2001, 33:1536–1544.

    Article  PubMed  CAS  Google Scholar 

  31. Miller MB, Hendren R, Gilligan PH: Posttransplantation disseminated coccidioidomycosis acquired from donor lungs. J Clin Microbiol 2004, 42:2347–2349.

    Article  PubMed  Google Scholar 

  32. Wright PW, Pappagianis D, Wilson M, et al.: Donor-related coccidioidomycosis in organ transplant recipients. Clin Infect Dis 2003, 37:1265–1269.

    Article  PubMed  Google Scholar 

  33. Blair JE, Kusne S, Carey EJ, Heilman RL: The prevention of recrudescent coccidioidomycosis after solid organ transplantation. Transplantation 2007, 83:1182–1187.

    Article  PubMed  Google Scholar 

  34. Blair JE, Douglas DD, Mulligan DC: Early results of targeted prophylaxis for coccidioidomycosis in patients undergoing orthotopic liver transplantation within an endemic area. Transpl Infect Dis 2003, 5:3–8.

    PubMed  CAS  Google Scholar 

  35. Joos L, Chhajed PN, Wallner J, et al.: Pulmonary infections diagnosed by BAL: a 12-year experience in 1066 immunocompromised patients. Respir Med 2007, 101:93–97.

    Article  PubMed  Google Scholar 

  36. Crosdale DJ, Poulton KV, Ollier WE, et al.: Mannose-binding lectin gene polymorphisms as a susceptibility factor for chronic necrotizing pulmonary aspergillosis. J Infect Dis 2001, 184:653–656.

    Article  PubMed  CAS  Google Scholar 

  37. Sullivan KM, Dykewicz CA, Longworth DL, et al.: Preventing opportunistic infections after hematopoietic stem cell transplantation: the Centers for Disease Control and Prevention, Infectious Diseases Society of America, and American Society for Blood and Marrow Transplantation Practice Guidelines and beyond. Hematology Am Soc Hematol Educ Program 2001, 392–421.

  38. Drew RH, Dodds Ashley E, Benjamin DK Jr, et al.: Comparative safety of amphotericin B lipid complex and amphotericin B deoxycholate as aerosolized antifungal prophylaxis in lung-transplant recipients. Transplantation 2004, 77:232–237.

    Article  PubMed  CAS  Google Scholar 

  39. Perfect JR, Cox GM, Lee JY, et al.: The impact of culture isolation of Aspergillus species: a hospital-based survey of aspergillosis. Clin Infect Dis 2001, 33:1824–1833.

    Article  PubMed  CAS  Google Scholar 

  40. Dummer JS, Lazariashvilli N, Barnes J, et al.: A survey of anti-fungal management in lung transplantation. J Heart Lung Transplant 2004, 23:1376–1381.

    Article  PubMed  Google Scholar 

  41. Husain S, Zaldonis D, Kusne S, et al.: Variation in antifungal prophylaxis strategies in lung transplantation. Transpl Infect Dis 2006, 8:213–218.

    Article  PubMed  CAS  Google Scholar 

  42. Peleg AY, Husain S, Kwak EJ, et al.: Opportunistic infections in 547 organ transplant recipients receiving alemtuzumab, a humanized monoclonal CD-52 antibody. Clin Infect Dis 2007, 44:204–212.

    Article  PubMed  CAS  Google Scholar 

  43. Reams BD, Musselwhite LW, Zaas DW, et al.: Alemtuzumab in the treatment of refractory acute rejection and bronchiolitis obliterans syndrome after human lung transplantation. Am J Transplant 2007, 7:2802–2808.

    Article  PubMed  CAS  Google Scholar 

  44. Denning DW: Invasive aspergillosis. Clin Infect Dis 1998, 26:781–805.

    Article  PubMed  CAS  Google Scholar 

  45. Behre GF, Schwartz S, Lenz K, et al.: Aerosol amphotericin B inhalations for prevention of invasive pulmonary aspergillosis in neutropenic cancer patients. Ann Hematol 1995, 71:287–291.

    Article  PubMed  CAS  Google Scholar 

  46. De Laurenzi A, Matteocci A, Lanti A, et al.: Amphotericin B prophylaxis against invasive fungal infections in neutropenic patients: a single center experience from 1980 to 1995. Infection 1996, 24:361–366.

    Article  PubMed  Google Scholar 

  47. Palmer SM, Drew RH, Whitehouse JD, et al.: Safety of aerosolized amphotericin B lipid complex in lung transplant recipients. Transplantation 2001, 72:545–548.

    Article  PubMed  CAS  Google Scholar 

  48. Monforte V, Roman A, Gavalda J, et al.: Nebulized amphotericin B concentration and distribution in the respiratory tract of lung-transplanted patients. Transplantation 2003, 75:1571–1574.

    Article  PubMed  CAS  Google Scholar 

  49. Dodds Ashley ES, Petry N, Drew RH, et al.: Characterization of aerosolized amphotericin B lipid complex (ABLC) lung distribution. Presented at the Society of Infectious Diseases Pharmacists. Washington, DC; December 17, 2005.

  50. Slavin MA, Osborne B, Adams R, et al.: Efficacy and safety of fluconazole prophylaxis for fungal infections after marrow transplantation—a prospective, randomized, double-blind study. J Infect Dis 1995, 171:1545–1552.

    PubMed  CAS  Google Scholar 

  51. Winston DJ, Pakrasi A, Busuttil RW: Prophylactic fluconazole in liver transplant recipients. A randomized, double-blind, placebo-controlled trial. Ann Intern Med 1999, 131:729–737.

    PubMed  CAS  Google Scholar 

  52. Marr KA, Seidel K, Slavin MA, et al.: Prolonged fluconazole prophylaxis is associated with persistent protection against candidiasis-related death in allogeneic marrow transplant recipients: long-term follow-up of a randomized, placebo-controlled trial. Blood 2000, 96:2055–2061.

    PubMed  CAS  Google Scholar 

  53. Marr KA, Crippa F, Leisenring W, et al.: Itraconazole versus fluconazole for prevention of fungal infections in patients receiving allogeneic stem cell transplants. Blood 2004, 103:1527–1533.

    Article  PubMed  CAS  Google Scholar 

  54. Marr KA, Leisenring W, Crippa F, et al.: Cyclophosphamide metabolism is affected by azole antifungals. Blood 2004, 103:1557–1559.

    Article  PubMed  CAS  Google Scholar 

  55. Alexander BD, Schell WA, Miller JL, et al.: Candida glabrata fungemia in transplant patients receiving voriconazole after fluconazole. Transplantation 2005, 80:868–871.

    Article  PubMed  Google Scholar 

  56. Imhof A, Balajee SA, Fredricks DN, et al.: Breakthrough fungal infections in stem cell transplant recipients receiving voriconazole. Clin Infect Dis 2004, 39:743–746.

    Article  PubMed  Google Scholar 

  57. Cornely OA, Maertens J, Winston DJ, et al.: Posaconazole vs fluconazole or itraconazole prophylaxis in patients with neutropenia. N Engl J Med 2007, 356:348–959.

    Article  PubMed  CAS  Google Scholar 

  58. Ullmann AJ, Lipton JH, Vesole DH, et al.: Posaconazole or fluconazole for prophylaxis in severe graft-versus-host disease. N Engl J Med 2007, 356:335–347.

    Article  PubMed  CAS  Google Scholar 

  59. Alexander BD, Perfect J, Daly J, et al.: Posaconazole as salvage therapy in patients with invasive fungal infections following solid organ transplant. Presented at the 45th Interscience Conference on Antimicrobial Agents and Chemotherapy. Washington, D.C.; December 16–19, 2005.

  60. Lorf T, Braun F, Ruchel R, et al.: Systemic mycoses during prophylactical use of liposomal amphotericin B (Ambisome) after liver transplantation. Mycoses 1999, 42:47–53.

    Article  PubMed  CAS  Google Scholar 

  61. Platelia Aspergillus EIA [package insert]. Redmond, WA: Bio-Rad Laboratories; 2006.

  62. Odabasi Z, Mattiuzzi G, Estey E, et al.: Beta-D-glucan as a diagnostic adjunct for invasive fungal infections: validation, cutoff development, and performance in patients with acute myelogenous leukemia and myelodysplastic syndrome. Clin Infect Dis 2004, 39:199–205.

    Article  PubMed  CAS  Google Scholar 

  63. Husain S, Kwak EJ, Obman A, et al.: Prospective assessment of Platelia Aspergillus galactomannan antigen for the diagnosis of invasive aspergillosis in lung transplant recipients. Am J Transplant 2004, 4:796–802.

    Article  PubMed  Google Scholar 

  64. Kwak EJ, Husain S, Obman A, et al.: Efficacy of galactomannan antigen in the Platelia Aspergillus enzyme immunoassay for diagnosis of invasive aspergillosis in liver transplant recipients. J Clin Microbiol 2004, 42:435–438.

    Article  PubMed  Google Scholar 

  65. Husain S, Paterson DL, Studer SM, et al.: Aspergillus galactomannan antigen in the bronchoalveolar lavage fluid for the diagnosis of invasive aspergillosis in lung transplant recipients. Transplantation 2007, 83:1330–1336.

    Article  PubMed  CAS  Google Scholar 

  66. Ostrosky-Zeichner L, Sable C, Sobel J, et al.: Multicenter retrospective development and validation of a clinical prediction rule for nosocomial invasive candidiasis in the intensive care setting. Eur J Clin Microbiol Infect Dis 2007, 26:271–276.

    Article  PubMed  CAS  Google Scholar 

  67. Pappas PG, Rex JH, Sobel JD, et al.: Guidelines for treatment of candidiasis. Clin Infect Dis 2004, 38:161–189.

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Medicine/Infectious Diseases, Duke University Medical Center, DUMC Box 3355, Durham, NC, 27710, USA

    Aimee K. Zaas

Authors
  1. Aimee K. Zaas
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Barbara D. Alexander
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Aimee K. Zaas.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Zaas, A.K., Alexander, B.D. Prevention of invasive fungal infections in lung transplant patients. Curr Fungal Infect Rep 2, 103–111 (2008). https://doi.org/10.1007/s12281-008-0016-0

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s12281-008-0016-0

Keywords

Search

Navigation